The ongoing soap opera that was the Bayer pursuit of Monsanto (MON) appears to have ended with a $66 billion dollar deal, or $128 a share. Monsanto's stock, however, is still trading near $107. Bernstein's Jonas Oxgaard and team spoke with investors before the deal was made official and offer some insights why that may be: ...we conducted an investor survey with 74 qrespondents in an attempt to gauge the deal's success probability and any other investor sentiment. 80% believe that Monsanto and Bayer will agree to a deal.
https://finance.yahoo.com/news/american-dream-city-living-built-133506175.html
GO MON
"PEACE"
$$$$$$ I'VE GOT MINE $$$$$$
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM